The Importance of Risk and Subgroup Analysis of Nonparticipants in a Geriatric Intervention Study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

The Importance of Risk and Subgroup Analysis of Nonparticipants in a Geriatric Intervention Study. / Rosted, Elizabeth; Poulsen, Ingrid; Hendriksen, Carsten; Wagner, Lis.

In: Scientifica, Vol. 2016, 2787282, 2016, p. 1-7.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Rosted, E, Poulsen, I, Hendriksen, C & Wagner, L 2016, 'The Importance of Risk and Subgroup Analysis of Nonparticipants in a Geriatric Intervention Study', Scientifica, vol. 2016, 2787282, pp. 1-7. https://doi.org/10.1155/2016/2787282

APA

Rosted, E., Poulsen, I., Hendriksen, C., & Wagner, L. (2016). The Importance of Risk and Subgroup Analysis of Nonparticipants in a Geriatric Intervention Study. Scientifica, 2016, 1-7. [2787282]. https://doi.org/10.1155/2016/2787282

Vancouver

Rosted E, Poulsen I, Hendriksen C, Wagner L. The Importance of Risk and Subgroup Analysis of Nonparticipants in a Geriatric Intervention Study. Scientifica. 2016;2016:1-7. 2787282. https://doi.org/10.1155/2016/2787282

Author

Rosted, Elizabeth ; Poulsen, Ingrid ; Hendriksen, Carsten ; Wagner, Lis. / The Importance of Risk and Subgroup Analysis of Nonparticipants in a Geriatric Intervention Study. In: Scientifica. 2016 ; Vol. 2016. pp. 1-7.

Bibtex

@article{6e05ec2294d248ac82d730fff73f4453,
title = "The Importance of Risk and Subgroup Analysis of Nonparticipants in a Geriatric Intervention Study",
abstract = "Background: A major concern in intervention studies is the generalizability of the findings due to refusal of intended participants to actually take part. In studies including ill older people the number of those declining to participate may be large and the concern is therefore relevant. Objectives: To compare patients characteristics, rates of acute readmission, and mortality after one and six months among older persons who agreed and those who declined to participate in a randomized controlled trial and to describe subgroups of nonparticipants. Design: Comparative study based on a randomized controlled trial. Setting: University hospital in the Capital Region of Denmark. Participants: Patients ≥70 years discharged home after a short Emergency Department stay. 399 were requested to participate; 271 consented, whereas 128 refused. Results: Refusers were more likely to be readmitted () or die (). The largest subgroup of refusers described as “too ill” had the highest risk of readmission (OR = 3.00, 95% CI = 1.61–5.47, ) and of mortality within six months (OR = 3.50, 95% CI = 1.64–7.49, ). However, this seems not to have affected the results of our randomized study. Conclusion: We recommend that intervention studies among older people or other fragile patient groups include analysis of relevant risk and subgroup analyses of refusers.",
author = "Elizabeth Rosted and Ingrid Poulsen and Carsten Hendriksen and Lis Wagner",
year = "2016",
doi = "10.1155/2016/2787282",
language = "English",
volume = "2016",
pages = "1--7",
journal = "Scientifica",
issn = "1813-0054",

}

RIS

TY - JOUR

T1 - The Importance of Risk and Subgroup Analysis of Nonparticipants in a Geriatric Intervention Study

AU - Rosted, Elizabeth

AU - Poulsen, Ingrid

AU - Hendriksen, Carsten

AU - Wagner, Lis

PY - 2016

Y1 - 2016

N2 - Background: A major concern in intervention studies is the generalizability of the findings due to refusal of intended participants to actually take part. In studies including ill older people the number of those declining to participate may be large and the concern is therefore relevant. Objectives: To compare patients characteristics, rates of acute readmission, and mortality after one and six months among older persons who agreed and those who declined to participate in a randomized controlled trial and to describe subgroups of nonparticipants. Design: Comparative study based on a randomized controlled trial. Setting: University hospital in the Capital Region of Denmark. Participants: Patients ≥70 years discharged home after a short Emergency Department stay. 399 were requested to participate; 271 consented, whereas 128 refused. Results: Refusers were more likely to be readmitted () or die (). The largest subgroup of refusers described as “too ill” had the highest risk of readmission (OR = 3.00, 95% CI = 1.61–5.47, ) and of mortality within six months (OR = 3.50, 95% CI = 1.64–7.49, ). However, this seems not to have affected the results of our randomized study. Conclusion: We recommend that intervention studies among older people or other fragile patient groups include analysis of relevant risk and subgroup analyses of refusers.

AB - Background: A major concern in intervention studies is the generalizability of the findings due to refusal of intended participants to actually take part. In studies including ill older people the number of those declining to participate may be large and the concern is therefore relevant. Objectives: To compare patients characteristics, rates of acute readmission, and mortality after one and six months among older persons who agreed and those who declined to participate in a randomized controlled trial and to describe subgroups of nonparticipants. Design: Comparative study based on a randomized controlled trial. Setting: University hospital in the Capital Region of Denmark. Participants: Patients ≥70 years discharged home after a short Emergency Department stay. 399 were requested to participate; 271 consented, whereas 128 refused. Results: Refusers were more likely to be readmitted () or die (). The largest subgroup of refusers described as “too ill” had the highest risk of readmission (OR = 3.00, 95% CI = 1.61–5.47, ) and of mortality within six months (OR = 3.50, 95% CI = 1.64–7.49, ). However, this seems not to have affected the results of our randomized study. Conclusion: We recommend that intervention studies among older people or other fragile patient groups include analysis of relevant risk and subgroup analyses of refusers.

U2 - 10.1155/2016/2787282

DO - 10.1155/2016/2787282

M3 - Journal article

C2 - 27446634

VL - 2016

SP - 1

EP - 7

JO - Scientifica

JF - Scientifica

SN - 1813-0054

M1 - 2787282

ER -

ID: 164383251